BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

564 related articles for article (PubMed ID: 28759866)

  • 1. Oral health impacts of medications used to treat mental illness.
    Cockburn N; Pradhan A; Taing MW; Kisely S; Ford PJ
    J Affect Disord; 2017 Dec; 223():184-193. PubMed ID: 28759866
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Managing the oral side-effects of medications used to treat multiple sclerosis.
    Cockburn N; Pateman K; Taing MW; Pradhan A; Ford PJ
    Aust Dent J; 2017 Sep; 62(3):331-336. PubMed ID: 28276076
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Using antipsychotic agents in older patients.
    Alexopoulos GS; Streim J; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2004; 65 Suppl 2():5-99; discussion 100-102; quiz 103-4. PubMed ID: 14994733
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Psychotropic drug use in older people with mental illness with particular reference to antipsychotics: a systematic study of tolerability and use in different diagnostic groups.
    Curran S; Turner D; Musa S; Wattis J
    Int J Geriatr Psychiatry; 2005 Sep; 20(9):842-7. PubMed ID: 16116576
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Psychotropic medication use in people living with severe and persistent mental illness in the Australian community: a cross-sectional study.
    Hu J; McMillan SS; Theodoros T; Collins JC; El-Den S; O'Reilly CL; Wheeler AJ
    BMC Psychiatry; 2022 Nov; 22(1):705. PubMed ID: 36380352
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Trends in the utilisation of psychotropic medications in Australia from 2000 to 2011.
    Stephenson CP; Karanges E; McGregor IS
    Aust N Z J Psychiatry; 2013 Jan; 47(1):74-87. PubMed ID: 23144164
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Psychotropic drugs].
    Müller-Spahn F
    Ther Umsch; 1999 Dec; 56(12):719-25. PubMed ID: 10638279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between xerostomia and psychotropic drugs in patients with schizophrenia: evaluation using an oral moisture meter.
    Okamoto A; Miyachi H; Tanaka K; Chikazu D; Miyaoka H
    J Clin Pharm Ther; 2016 Dec; 41(6):684-688. PubMed ID: 27663579
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prolonged QT Interval in Patients Receiving Psychotropic Medications.
    Swenson RS; Murphy-Ende K
    J Am Psychiatr Nurses Assoc; 2020; 26(4):344-353. PubMed ID: 31509051
    [No Abstract]   [Full Text] [Related]  

  • 10. Psychopharmacology in pregnancy.
    Gjere NA
    J Perinat Neonatal Nurs; 2001 Mar; 14(4):12-25. PubMed ID: 11930520
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cutaneous adverse reactions to psychotropic drugs: data from a multicenter surveillance program.
    Lange-Asschenfeldt C; Grohmann R; Lange-Asschenfeldt B; Engel RR; Rüther E; Cordes J
    J Clin Psychiatry; 2009 Sep; 70(9):1258-65. PubMed ID: 19538904
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Somatic side effects of psychopharmaceuticals].
    Schmidmeier R
    MMW Fortschr Med; 2006 Nov; 148(46):27-9. PubMed ID: 17615784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of seizures associated with psychotropic medications: emphasis on new drugs and new findings.
    Lee KC; Finley PR; Alldredge BK
    Expert Opin Drug Saf; 2003 May; 2(3):233-47. PubMed ID: 12904103
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are psychotropic drugs at therapeutic levels a concern for cardiologists?
    Burggraf GW
    Can J Cardiol; 1997 Jan; 13(1):75-80. PubMed ID: 9039069
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rational polypharmacy in the bipolar affective disorders.
    Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
    Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyperprolactinemia associated with psychotropics--a review.
    Madhusoodanan S; Parida S; Jimenez C
    Hum Psychopharmacol; 2010; 25(4):281-97. PubMed ID: 20521318
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Psychotropic-associated sexual dysfunctions: a survey of clinical pharmacology and medication-associated practice].
    Santini I; De Lauretis I; Roncone R; Tosone A; Bianchini V; D'Onofrio S; Ortenzi R; Giusti L; Casacchia M; Pollice R
    Clin Ter; 2014; 165(3):e243-52. PubMed ID: 24999583
    [TBL] [Abstract][Full Text] [Related]  

  • 18. National trends in psychotropic medication polypharmacy in office-based psychiatry.
    Mojtabai R; Olfson M
    Arch Gen Psychiatry; 2010 Jan; 67(1):26-36. PubMed ID: 20048220
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacogenetics of psychotropic drug response.
    Malhotra AK; Murphy GM; Kennedy JL
    Am J Psychiatry; 2004 May; 161(5):780-96. PubMed ID: 15121641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medication for psychosis--consumption and consequences: the second Australian national survey of psychosis.
    Waterreus A; Morgan VA; Castle D; Galletly C; Jablensky A; Di Prinzio P; Shah S
    Aust N Z J Psychiatry; 2012 Aug; 46(8):762-73. PubMed ID: 22689337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.